Clinical Trials

NCT06206135 | RECRUITING

172 participants

Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-21

Completion:

2028-02-28

Conditions

• Hyperphosphatemia

Interventions

• DRUG

No Results Yet

NCT06205628 | ACTIVE_NOT_RECRUITING | PHASE1

28 participants

Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-03-21

Completion:

2026-07-31

Conditions

• Hypertension
• Hypertension,Essential

Interventions

• DRUG

No Results Yet

NCT06195982 | COMPLETED | PHASE2

25 participants

Ketones in Heart Failure With Reduced Ejection Fraction

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-03-06

Completion:

2026-08-27

Conditions

• Heart Failure With Reduced Ejection Fraction

Interventions

• DIETARY_SUPPLEMENT

No Results Yet

NCT06177639 | COMPLETED

18 participants

Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2025-10-01

Completion:

2026-04-22

Conditions

• Eye Diseases

Interventions

• DEVICE

No Results Yet

NCT06171256 | WITHHELD

[Trial of device that is not approved or cleared by the U.S. FDA]

Last Updated:

2026-09-03

No Results Yet

NCT06170788 | RECRUITING | PHASE3

614 participants

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-15

Completion:

2028-01-25

Conditions

• Non-small Cell Lung Cancer (NSCLC)

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT06170216 | COMPLETED

206 participants

Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2023-01-10

Completion:

2023-12-19

Conditions

• Lymphoma, Non-Hodgkin

Interventions

• DRUG

No Results Yet

NCT06163534 | RECRUITING

500 participants

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2024-08-01

Completion:

2028-03-01

Conditions

• Head and Neck Squamous Cell Carcinoma

No Results Yet

NCT06156410 | RECRUITING | PHASE1

30 participants

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-10-24

Completion:

2027-11-30

Conditions

• Ewing Sarcoma
• Osteosarcoma
• Sarcomas

Interventions

• DRUG

No Results Yet

NCT06143293 | ACTIVE_NOT_RECRUITING | NA

144 participants

RESEARCH EVALUATING VAGAL EXCITATION AND ANATOMICAL LINKS

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-15

Completion:

2027-08-31

Conditions

• Epilepsy
• Depressive Disorder

Interventions

• DEVICE

No Results Yet

NCT06138067 | RECRUITING | NA

90 participants

Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-12-01

Completion:

2027-09-30

Conditions

• Prostate Cancer
• Kidney Cancer

Interventions

• BEHAVIORAL

No Results Yet

NCT06137261 | ACTIVE_NOT_RECRUITING | NA

420 participants

Screening Adults With Obesity to Reduce Heart Failure Events

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-02-26

Completion:

2026-12-08

Conditions

• Obesity
• Heart Failure

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT06136624 | RECRUITING | PHASE3

1310 participants

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-31

Completion:

2028-08-02

Conditions

• Prostate Cancer Metastatic

Interventions

• DRUG

No Results Yet

NCT06129864 | RECRUITING | PHASE3

1145 participants

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-14

Completion:

2030-04-17

Conditions

• Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions

• DRUG

No Results Yet

NCT06128447 | RECRUITING | PHASE3

300 participants

Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-02-14

Completion:

2027-03-01

Conditions

• Soil-Transmitted Helminthiasis (STH)

Interventions

• DRUG

No Results Yet

NCT06125847 | RECRUITING | EARLY_PHASE1

21 participants

NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-10-29

Completion:

2027-03-30

Conditions

• Homozygous Familial Hypercholesterolemia

Interventions

• GENETIC

No Results Yet

NCT06115265 | RECRUITING | NA

40 participants

Ketogenic Diet and Diabetes Demonstration Project

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-09-05

Completion:

2026-10-30

Conditions

• Type 2 Diabetes
• PreDiabetes
• Obesity
• Ketogenic Dieting

Interventions

• BEHAVIORAL

No Results Yet

NCT06096870 | RECRUITING | PHASE2

65 participants

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-04-22

Completion:

2028-12-31

Conditions

• Prostate Cancer
• Recurrent Prostate Cancer
• PET Positive

Interventions

• DRUG

No Results Yet

NCT06084936 | RECRUITING | PHASE3

182 participants

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-10-22

Completion:

2027-08-31

Conditions

• Lymphoma

Interventions

• DRUG

No Results Yet

NCT06079567 | RECRUITING | NA

50 participants

An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-10-03

Completion:

2028-03-31

Conditions

• Facioscapulohumeral Muscular Dystrophy Type 2

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT06077864 | COMPLETED | PHASE3

5531 participants

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-11-20

Completion:

2026-06-01

Conditions

• Obesity

Interventions

• COMBINATION_PRODUCT

No Results Yet

NCT06073067 | RECRUITING | NA

20 participants

GRID Therapy for Extremity Soft Tissue Sarcoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-11-09

Completion:

2026-11-10

Conditions

• Sarcoma

Interventions

• RADIATION

No Results Yet

NCT06065748 | RECRUITING | PHASE3

1050 participants

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-11

Completion:

2027-02-19

Conditions

• Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

Interventions

• DRUG
• DIAGNOSTIC_TEST

No Results Yet

NCT06058520 | RECRUITING | EARLY_PHASE1

16 participants

Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-27

Completion:

2026-12-30

Conditions

• Hidradenitis Suppurativa

Interventions

• DRUG

No Results Yet

NCT06055920 | ACTIVE_NOT_RECRUITING | NA

1200 participants

The PEERLESS II Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-11-17

Completion:

2026-07-30

Conditions

• Pulmonary Embolism

Interventions

• DEVICE
• DRUG

No Results Yet

NCT06055881 | ACTIVE_NOT_RECRUITING | NA

45 participants

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-10-23

Completion:

2026-10-26

Conditions

• Breast Carcinoma
• Anatomic Stage IV Breast Cancer AJCC v8
• Metastatic Breast Cancer

Interventions

• PROCEDURE
• OTHER
• RADIATION

No Results Yet

NCT06054893 | ACTIVE_NOT_RECRUITING | PHASE1

33 participants

A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-07-01

Completion:

2030-06-04

Conditions

• Friedreich Ataxia

Interventions

• DRUG

No Results Yet

NCT06043037 | COMPLETED | NA

50 participants

Elamrousy Modified Approach for Socket Shield Technique

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-07-18

Completion:

2026-07-31

Conditions

• Implant Site Reaction
• Tooth Extraction Status Nos
• Dental Implant Failed

Interventions

• PROCEDURE

No Results Yet

NCT06029270 | RECRUITING | PHASE2

156 participants

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-07-15

Completion:

2029-04-30

Conditions

• Metastatic Nasopharyngeal Carcinoma
• Recurrent Nasopharyngeal Carcinoma
• Stage IV Nasopharyngeal Carcinoma AJCC v8

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL

No Results Yet

NCT06026124 | COMPLETED | NA

27 participants

Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2022-10-31

Completion:

2024-09-17

Conditions

• Developmental Language Disorder
• Specific Language Impairment
• Language Development

Interventions

• BEHAVIORAL

Results Available

NCT05987410 | RECRUITING | NA

105 participants

EffectiVenEss of a Rehabilitation Treatment With Nordic Walking in obEse or oveRweight Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-01

Completion:

2028-09-30

Conditions

• Cardiovascular Diseases
• Diabete Type 2
• Overweight and Obesity

Interventions

• OTHER

No Results Yet

NCT05984628 | RECRUITING | NA

88 participants

Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2021-10-20

Completion:

2027-12-31

Conditions

• Skin Wound
• Scar, Hypertrophic

Interventions

• PROCEDURE

No Results Yet

NCT05981105 | ACTIVE_NOT_RECRUITING | NA

64 participants

Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-06-12

Completion:

2024-11-07

Conditions

• Chronic Pain
• Opioid Use
• Adductor Canal Block
• Total Knee Arthroplasty

Interventions

• DEVICE

No Results Yet

NCT05974111 | COMPLETED

379 participants

COAgulation Disorders in Ischaemic and Haemorrhagic Stroke

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2023-05-02

Completion:

2025-08-02

Conditions

• Ischemic Stroke
• Haemorrhagic Stroke
• Aneurysmal Subarachnoid Hemorrhage

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT05971940 | COMPLETED | PHASE3

559 participants

A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-08-09

Completion:

2025-04-03

Conditions

• Type 2 Diabetes

Interventions

• DRUG

Results Available

NCT05960773 | RECRUITING | PHASE2

15 participants

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-01-31

Completion:

2028-07-01

Conditions

• Mesothelioma
• Malignant Mesothelioma (MM)
• Early-stage Mesothelioma
• Subclinical Mesothelioma
• BRCA1-Associated Protein-1 (BAP1) Mutations
• Early-stage BAP1-associated Malignancies

Interventions

• DRUG

No Results Yet

NCT05950464 | RECRUITING | PHASE1

65 participants

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-18

Completion:

2027-06-30

Conditions

• Recurrent Endometrial Carcinoma
• Recurrent Endometrial Clear Cell Adenocarcinoma
• Recurrent Endometrial Endometrioid Adenocarcinoma
• Recurrent Endometrial Low Grade Endometrioid Adenocarcinoma
• Recurrent Ovarian Clear Cell Adenocarcinoma
• Recurrent Ovarian Endometrioid Adenocarcinoma
• Recurrent Ovarian High Grade Serous Adenocarcinoma
• Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma
• Recurrent Platinum-Resistant Ovarian Carcinoma

Interventions

• DRUG
• PROCEDURE

No Results Yet

NCT05940623 | RECRUITING | NA

142 participants

Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-09-18

Completion:

2028-06-30

Conditions

• Glaucoma
• Intraocular Pressure
• Primary Open Angle Glaucoma

Interventions

• DEVICE
• BEHAVIORAL

No Results Yet

NCT05927571 | RECRUITING | PHASE1

120 participants

A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-08-10

Completion:

2027-07-31

Conditions

• Relapsed or Refractory Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT05911997 | COMPLETED | PHASE1

38 participants

MTC Versus FMT in for RCDI

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-01-08

Completion:

2025-11-13

Conditions

• Clostridiodies Difficile Infections

Interventions

• DRUG

No Results Yet